SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+130.12%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$355M
AUM Growth
+$355M
(+59%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
41.98%
Top 10 Holdings %
Top 10 Hldgs %
59.98%
Holding
61
New
22
Increased
9
Reduced
5
Closed
9
Top Buys
| 1 |
Icon
ICLR
|
$41M |
| 2 |
Cigna
CI
|
$19.7M |
| 3 |
Sanofi
SNY
|
$18.7M |
| 4 |
Maximus
MMS
|
$16.9M |
| 5 |
DRUG
Bright Minds Biosciences
DRUG
|
$16.3M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$24.3M |
| 2 |
Labcorp
LH
|
$13.8M |
| 3 |
Kenvue
KVUE
|
$11M |
| 4 |
Biodesix
BDSX
|
$7.72M |
| 5 |
Disc Medicine
IRON
|
$7.25M |
Sector Composition
| 1 | Healthcare | 91.96% |
| 2 | Industrials | 8.01% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Icon
ICLR
$13.8B
| $41M | 11.54% | +195,500 | New | +$41M |
|
|
2
Maximus
MMS
$4.95B
| $28.5M | 8.01% | 381,423 +226,281 | +146% | +$16.9M |
|
|
3
Cigna
CI
$80.3B
| $27.1M | 7.61% | 98,003 +71,500 | +270% | +$19.7M |
|
|
4
Labcorp
LH
$23.1B
| $26M | 7.31% | 113,293 -60,000 | -35% | -$13.8M |
|
|
5
Sanofi
SNY
$121B
| $18.7M | 5.25% | +387,000 | New | +$18.7M |
|
6
Zimmer Biomet
ZBH
$21B
| $18.5M | 5.2% | 174,811 +47,300 | +37% | +$5M |
|
|
DRUG
7
Bright Minds Biosciences
DRUG
$276M
| $16.3M | 4.58% | +451,793 | New | +$16.3M |
|
|
AVR
8
Anteris Technologies Global Corp. Common Stock
AVR
$145M
| $13.2M | 3.72% | +2,370,000 | New | +$13.2M |
|
9
Annexon
ANNX
$226M
| $12.1M | 3.42% | 2,367,007 +933,852 | +65% | +$4.79M |
|
10
Teleflex
TFX
$5.59B
| $11.9M | 3.34% | 66,772 +27,500 | +70% | +$4.89M |
|
11
Viatris
VTRS
$12.3B
| $9.09M | 2.56% | +730,000 | New | +$9.09M |
|
12
Organon & Co
OGN
$2.45B
| $9.05M | 2.55% | +606,410 | New | +$9.05M |
|
13
Ventyx Biosciences
VTYX
$171M
| $8.86M | 2.49% | 4,046,797 +2,074,849 | +105% | +$4.54M |
|
14
ANI Pharmaceuticals
ANIP
$2.03B
| $8.85M | 2.49% | +160,051 | New | +$8.85M |
|
15
Embecta
EMBC
$847M
| $8.79M | 2.47% | +425,574 | New | +$8.79M |
|
16
Vir Biotechnology
VIR
$686M
| $7.74M | 2.18% | +1,054,651 | New | +$7.74M |
|
|
VXRT
17
DELISTED
Vaxart
VXRT
| $7.62M | 2.15% | 11,515,315 -2,092,929 | -15% | -$1.39M |
|
18
Protara Therapeutics
TARA
$120M
| $7.59M | 2.14% | +1,437,500 | New | +$7.59M |
|
|
CRGX
19
DELISTED
CARGO Therapeutics
CRGX
| $6.82M | 1.92% | 473,292 +299,432 | +172% | +$4.32M |
|
20
Neumora Therapeutics
NMRA
$280M
| $6.74M | 1.9% | +636,300 | New | +$6.74M |
|
|
SEPN
21
Septerna, Inc. Common Stock
SEPN
$539M
| $6.22M | 1.75% | +271,687 | New | +$6.22M |
|
22
ProQR Therapeutics
PRQR
$237M
| $5.44M | 1.53% | +2,054,593 | New | +$5.44M |
|
23
PMV Pharmaceuticals
PMVP
$74.2M
| $5.39M | 1.52% | 3,572,167 +357,928 | +11% | +$540K |
|
|
24
Disc Medicine
IRON
$2.07B
| $4.66M | 1.31% | 73,511 -114,430 | -61% | -$7.25M |
|
25
Astria Therapeutics
ATXS
$349M
| $4.51M | 1.27% | 504,887 | – | – |
|